Kenya has received 21,000 doses of the long-acting HIV prevention injection Lenacapavir, with rollout set to begin in March.

Kenya officially announced the introduction of a groundbreaking long-acting injectable HIV prevention drug, Lenacapavir, ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - A pharmacist holds a vial of lenacapavir, an injectable HIV prevention drug, at the Desmond Tutu Health Foundation's ...

Please provide your email address to receive an email when new articles are posted on . Many real-world patients added lenacapavir while already suppressed. More than half of patients simplified ...

The U.S. Food and Drug Administration (FDA) recently approved a groundbreaking new option for preventing HIV, the virus that causes AIDS. The injectable drug lenacapavir was approved in June and is ...

Gilead Sciences, Inc. GILD announced that the investigational single-tablet regimen of bictegravir and lenacapavir for the treatment of HIV met the primary endpoint in the late-stage ARTISTRY-2 study.

Gilead Announces Partnership With PEPFAR to Deliver Twice-Yearly Lenacapavir for HIV Prevention for up to Two Million People in Primarily Low- and Lower-Middle-Income Countries – PEPFAR, Coordinated ...

On 14 July 2025, the World Health Organization (WHO) issued new guidelines recommending twice-yearly injectable lenacapavir as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention.

Add Yahoo as a preferred source to see more of our stories on Google. Two men, with one looking at the camera while the other looks past the other As Congress nears a January deadline to pass a ...

– PEPFAR, Coordinated by the U.S. State Department, will Support Delivery of Lenacapavir for PrEP in High-Incidence, Resource-Limited Countries as Key Part of Strategic Efforts with Global Fund to ...